Page last updated: 2024-10-24

chlorambucil and Leprosy

chlorambucil has been researched along with Leprosy in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rollier, R1
Cherkaoui, A1

Other Studies

1 other study available for chlorambucil and Leprosy

ArticleYear
[A case of cutaneous leukemia].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1969, Volume: 76, Issue:6

    Topics: Aged; Chlorambucil; Diagnosis, Differential; Female; Humans; Leprosy; Leukemia, Lymphoid; Skin Neopl

1969